PNW
50
-2
PGR
52
3
SCHW
64
2
GOOG
59
-10
RIG
14
-2
AIV
62
11
AFL
46
2
MU
63
-4
NI
77
2
HPQ
46
2
WY
27
-4
DD
46
-2
KO
44
2
CMI
47
2
PBI
60
-2
NWL
44
9
IRM
47
5
HBAN
80
-2
HON
62
4
PEP
33
6
PNW
50
-2
PGR
52
3
SCHW
64
2
GOOG
59
-10
RIG
14
-2
AIV
62
11
AFL
46
2
MU
63
-4
NI
77
2
HPQ
46
2
WY
27
-4
DD
46
-2
KO
44
2
CMI
47
2
PBI
60
-2
NWL
44
9
IRM
47
5
HBAN
80
-2
HON
62
4
PEP
33
6
Financhill
Back

Allegiant Travel Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
35

ALGT
Allegiant Travel

Last Price:
$55.81
Seasonality Move:
-0.41%
Sell
22

APLS
Apellis Pharmaceuticals

Last Price:
$17.44
Seasonality Move:
-14.59%
Sell
35
Allegiant Travel (ALGT) is a Sell

Is Allegiant Travel a Buy, Sell or Hold?

  • The current Allegiant Travel [ALGT] share price is $55.71. The Score for ALGT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ALGT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.43. The Score for APLS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALGT Stock Price Chart

What is Allegiant Travel's stock price today?

  • The Allegiant Travel share price today is $55.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGT is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

ALGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 54.6 Buy
Chaikin Money Flow: -14262 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.36 - 56.74) Buy
Bollinger Bands (100): (44.95 - 73.19) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 41.91 Sell
Chaikin Money Flow: -3543940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.42 - 19.1) Sell
Bollinger Bands (100): (17.42 - 25.66) Sell

ALGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.98 Buy
20-day SMA: 54.52 Buy
50-day SMA: 52.36 Buy
200-day SMA: 66.15 Sell
8-day EMA: 53.96 Buy
20-day EMA: 53.95 Buy
50-day EMA: 54.69 Buy
200-day EMA: 62.38 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.96 Sell
20-day SMA: 18.5 Sell
50-day SMA: 18.15 Sell
200-day SMA: 26.32 Sell
8-day EMA: 18.1 Sell
20-day EMA: 18.25 Sell
50-day EMA: 19.02 Sell
200-day EMA: 26.54 Sell

Allegiant Travel Earnings Growth & ALGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.79 per share, an increase next quarter of $3.00 per share, an increase this year of $0.96 per share, and an increase next year of $3.15 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.13 per share, and an increase next year of $1.13 per share.

Allegiant Travel Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):